Vogt-Koyanagi-Harada disease in pediatric, adult and elderly: clinical characteristics and visual outcomes.

[1]  Yuqin Wang,et al.  Comparison of the Three Sets of Diagnostic Criteria for Vogt-Koyanagi-Harada Disease in Southeast China - A Retrospective Case-Control Study. , 2022, Ocular immunology and inflammation.

[2]  R. George,et al.  Vogt-Koyanagi-Harada Disease in Pre-school Children. , 2022, Ocular immunology and inflammation.

[3]  Keitaro Hase,et al.  The Steroid-Sparing Effect of Adalimumab in the Treatment for the Recurrent Phase of Vogt–Koyanagi–Harada Disease , 2022, Ocular immunology and inflammation.

[4]  S. Ohno,et al.  Editorial: New Insights Into Uveitis: Immunity, Genes, and Microbes , 2021, Frontiers in Immunology.

[5]  A. Kijlstra,et al.  Activation of the interleukin-23/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis , 2020, Progress in Retinal and Eye Research.

[6]  Peizeng Yang.  Atlas of Uveitis: Diagnosis and Treatment , 2021 .

[7]  M. Marquezan,et al.  Vogt-Koyanagi-Harada Syndrome in Brazilian Children , 2020, Ocular immunology and inflammation.

[8]  A. Kijlstra,et al.  Comparison of Clinical Features and Visual Outcome between Sympathetic Ophthalmia and Vogt-Koyanagi-Harada Disease in Chinese Patients. , 2019, Ophthalmology.

[9]  A. Kijlstra,et al.  Development and Evaluation of Diagnostic Criteria for Vogt-Koyanagi-Harada Disease , 2018, JAMA ophthalmology.

[10]  L. Du,et al.  How To Deal With Uveitis Patients? , 2018, Current molecular medicine.

[11]  A. Kijlstra,et al.  Novel treatment regimen of Vogt–Koyanagi–Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents , 2018, Current eye research.

[12]  S. Androudi,et al.  A Focus on the Epidemiology of Uveitis , 2018, Ocular immunology and inflammation.

[13]  James R. Staley,et al.  Semiparametric methods for estimation of a nonlinear exposure‐outcome relationship using instrumental variables with application to Mendelian randomization , 2017, bioRxiv.

[14]  A. Kijlstra,et al.  Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment , 2016, Progress in Retinal and Eye Research.

[15]  T. Kaburaki,et al.  Vogt–Koyanagi–Harada disease in 3‐year‐old boy , 2015, Clinical & experimental ophthalmology.

[16]  Chi-Chao Chan,et al.  Macrophage polarization in the maculae of age‐related macular degeneration: A pilot study , 2011, Pathology international.

[17]  D. Kangave,et al.  Vogt-Koyanagi-Harada disease in children , 2008, Eye.

[18]  S. Rathinam,et al.  Global variation and pattern changes in epidemiology of uveitis. , 2007, Indian journal of ophthalmology.

[19]  K. Kimoto,et al.  Vogt–Koyanagi–Harada disease in elderly Japanese patients , 2007, International Ophthalmology.

[20]  Q. Meng,et al.  Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. , 2007, Ophthalmology.

[21]  A. Fukushima,et al.  Vogt-Koyanagi-Harada Disease with Onset in Elderly Patients Aged 68 to 89 Years , 2007, Japanese Journal of Ophthalmology.

[22]  G. Peyman,et al.  Management of Pediatric Vogt-Koyanagi- Harada (VKH)-Associated Panuveitis , 2006, Ocular immunology and inflammation.

[23]  Y. Hayasaka,et al.  Uveitis and Pseudouveitis Presenting for the First Time in Japanese Elderly Patients , 2005, Ophthalmologica.

[24]  Douglas A Jabs,et al.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. , 2005, American journal of ophthalmology.

[25]  W. Freeman,et al.  Vogt-Koyanagi-Harada syndrome in children compared to adults. , 1998, Acta ophthalmologica Scandinavica.

[26]  E. Cunningham,et al.  Vogt-Koyanagi-Harada syndrome in children. , 1998, Ocular immunology and inflammation.